← Leaderboards
John M Buatti
University Of Florida
$4,178,356
Attributed
$10,200,967
Total exposure
7
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2010–24$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$10,200,967 · 7
By mechanism
U01$5,802,110 · 1
R01$1,960,897 · 1
P01$868,727 · 1
R21$730,765 · 2
R56$537,055 · 1
M01$301,413 · 1
Top collaborators
- Milan Sonka16 shared
- Thomas L. Casavant10 shared
- Michael M. Graham10 shared
- Bryan Allen2 shared
- Daniel J Berg2 shared
- Douglas Robert Spitz2 shared
Most similar at University Of Florida
Same institution · by research overlap
- David D Fuller$12,096,681
- Yunchao Su$4,504,620
- Sanjay Ranka$2,408,626
- Ashley Smuder$4,324,646
- Gordon Stewart Mitchell$30,134,377
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseResponseCancer TherapyImageInnovationClinical ResearchImage AnalysisClinical TrialsMalignant NeoplasmsComplexData SetResearch Project GrantsUniversitiesFuturePet/Ct ScanIowaMagnetic Resonance ImagingAlgorithmsMalignant Neoplasm Of LungManualsAscorbic AcidCancer ImagingDosePublications
Grant awards (29)
Redox manipulation of iron to improve glioblastoma therapy: A phase 1 trial$172,653
R21 · FY2024 · CA
Deep LOGISMOS$537,055
R56 · FY2023 · EB
Redox manipulation of iron to improve glioblastoma therapy: A phase 1 trial$218,089
R21 · FY2023 · CA
Deep LOGISMOS$396,286
R01 · FY2022 · EB
Deep LOGISMOS: Hippocampal Plasticity in Alzheimer's Disease (Admin. Supplement)$370,055
R01 · FY2022 · EB
Core C - Clinical Trials$169,603
P01 · FY2022 · CA · contact PI
Deep LOGISMOS$388,359
R01 · FY2021 · EB
Core C - Clinical Trials$176,102
P01 · FY2021 · CA · contact PI
Deep LOGISMOS$396,286
R01 · FY2020 · EB
Core C - Clinical Trials$176,102
P01 · FY2020 · CA · contact PI
Quantitative Imaging to Assess Response in Cancer Therapy Trials$603,792
U01 · FY2019 · CA · contact PI
Deep LOGISMOS$409,911
R01 · FY2019 · EB
Core C - Clinical Trials$170,818
P01 · FY2019 · CA · contact PI
Quantitative Imaging to Assess Response in Cancer Therapy Trials$622,467
U01 · FY2018 · CA · contact PI
Core C - Clinical Trials$176,102
P01 · FY2018 · CA · contact PI
Quantitative Imaging to Assess Response in Cancer Therapy Trials$622,467
U01 · FY2017 · CA · contact PI
Quantitative Imaging to Assess Response in Cancer Therapy Trials$622,467
U01 · FY2016 · CA · contact PI
Quantitative Imaging to Assess Response in Cancer Therapy Trials$617,490
U01 · FY2015 · CA · contact PI
Quantitative Imaging to Assess Response in Cancer Therapy Trials$501,587
U01 · FY2014 · CA · contact PI
Quantitative Imaging to Assess Response in Cancer Therapy Trials$499,351
U01 · FY2013 · CA · contact PI
Quantitative Imaging to Assess Response in Cancer Therapy Trials$545,255
U01 · FY2012 · CA · contact PI
Using Ketogenic Diets to Enhance Radio-Chemo-Therapy Response: A Phase I Trial$153,590
R21 · FY2012 · CA
Quantitative Imaging to Assess Response in Cancer Therapy Trials$560,046
U01 · FY2011 · CA · contact PI
Using Ketogenic Diets to Enhance Radio-Chemo-Therapy Response: A Phase I Trial$186,433
R21 · FY2011 · CA
Quantitative Imaging to Assess Response in Cancer Therapy Trials$607,188
U01 · FY2010 · CA · contact PI
CARBOGEN BREATHING DURING ACCELERATED HYPERFRACTIONATED RADIOTHERAPY FOR CANCER$207,281
M01 · FY2001 · RR
CARBOGEN BREATHING DURING ACCELERATED HYPERFRACTIONATED RADIOTHERAPY FOR CANCER$55,741
M01 · FY2001 · RR
CARBOGEN BREATHING DURING ACCELERATED HYPERFRACTIONATED RADIOTHERAPY FOR CANCER$38,391
M01 · FY2000 · RR
CARBOGEN BREATHING DURING ACCELERATED HYPERFRACTIONATED RADIOTHERAPY FOR CANCER$0
M01 · FY2000 · RR